Beyond the Blockbuster: Sanofi and Regeneron Renew Their High-Stakes Immunology Alliance on October 1, 2026 Posted by
Strategic Evolution: Sanofi and Regeneron Forge $8 Billion Alliance to Secure Immunology Leadership on October 1, 2026 Posted by
The Great Displacement: Why AI’s Cognitive Leap Is Leaving Humanity Behind on October 1, 2026 Posted by
Beyond the Scan: New Research Refines the Role of Coronary Calcium Testing in Heart Health on October 1, 2026 Posted by
Beyond the Mission: Meet Lauren Belsky, the Engine Behind the Alliance for Aging Research’s Growth on October 1, 2026 Posted by
Honoring the Pillars of Our Community: Celebrating World Senior Citizens Day on October 1, 2026 Posted by
Beyond the Blockbuster: Sanofi and Regeneron Renew Their High-Stakes Immunology Alliance on October 1, 2026 Posted by
Strategic Evolution: Sanofi and Regeneron Forge $8 Billion Alliance to Secure Immunology Leadership on October 1, 2026 Posted by
The Great Displacement: Why AI’s Cognitive Leap Is Leaving Humanity Behind on October 1, 2026 Posted by
Beyond the Scan: New Research Refines the Role of Coronary Calcium Testing in Heart Health on October 1, 2026 Posted by
Posted in Digital Health Tools A New Dawn for Sanfilippo Syndrome: FDA Greenlights Breakthrough Gene Therapy on September 18, 2026
Posted in Medical Innovations Pivot to the Heart: Cellectis Abandons Allogeneic Cell Therapy Ambitions to Pursue Cardiovascular Gene Editing on September 15, 2026
Posted in Medical Innovations Navigating the Regulatory Storm: UniQure’s High-Stakes Path for Huntington’s Gene Therapy on September 2, 2026
Posted in Digital Health Tools A Medical Milestone: FDA Approves First Gene Therapy for Glycogen Storage Disease Type Ia on August 28, 2026
Posted in Medical Innovations Clinical Roadblock: Regenxbio’s Hunter Syndrome Gene Therapy Faces New FDA Hurdle on August 24, 2026
Posted in Medical Innovations Regulatory Setback: Regenxbio Pauses Gene Therapy Trials Following Spinal Mass Findings on August 24, 2026
Posted in Digital Health Tools PTC Therapeutics Secures Late-Stage Gene Therapy Asset in High-Stakes Bankruptcy Auction on August 23, 2026
Posted in Medical Innovations A New Dawn for GSDIa: FDA Approves First Gene Therapy for Von Gierke Disease on August 21, 2026
Posted in Digital Health Tools From Cornstarch to Gene Therapy: The Landmark FDA Approval for GSDIa on August 20, 2026
Posted in Medical Innovations Advancements in Medicine: From Gene-Editing Breakthroughs to Dementia Prevention on August 15, 2026
